Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:ESRX

Express Scripts (ESRX) Stock Price, News & Analysis

Express Scripts logo

About Express Scripts Stock (NASDAQ:ESRX)

Key Stats

Today's Range
$92.11
$95.87
50-Day Range
$92.33
$92.33
52-Week Range
$66.93
$101.73
Volume
31.61 million shs
Average Volume
6.64 million shs
Market Capitalization
$52.06 billion
P/E Ratio
13.00
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services. This segment also provides Medicare, Medicaid, and health insurance marketplace products; Express Scripts SafeGuardRx, a suite of solutions targeting the therapy classes that pose clinical challenges and budgetary threat to its clients; and Inside Rx, a program that provide affordable access to medication for uninsured and underinsured individuals. Its Other Business Operations segment distributes specialty pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides medical benefit management solutions for radiology, cardiology, musculoskeletal disorders, sleep disorders, post-acute care, genetic lab, specialty pharmacy, and medical oncology. The company serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, providers, clinics, hospitals, and others. As of December 31, 2017, it operated 4 automated dispensing home delivery pharmacies; 1 non-automated dispensing home delivery pharmacy; 7 non-dispensing order processing centers; 5 patient contact centers; 9 specialty home delivery pharmacies; and 34 specialty branch pharmacies. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in Saint Louis, Missouri.

Receive ESRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Express Scripts and its competitors with MarketBeat's FREE daily newsletter.

ESRX Stock News Headlines

How to submit a script to us
Download Our Tesla Ebook For Free
Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.
See More Headlines

ESRX Stock Analysis - Frequently Asked Questions

Express Scripts Holding (NASDAQ:ESRX) released its earnings results on Wednesday, October, 31st. The company reported $2.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.42 by $0.01. The company's revenue was up 3.6% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Express Scripts investors own include Meta Platforms (META), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Walt Disney (DIS), Intel (INTC), Bank of America (BAC) and CVS Health (CVS).

Company Calendar

Last Earnings
10/31/2018
Today
11/21/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Stores & Proprietary Stores
Sub-Industry
Health Care Services
Current Symbol
NASDAQ:ESRX
CUSIP
30219G10
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$4.52 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$100.06 billion
Cash Flow
$10.49 per share
Book Value
$32.00 per share

Miscellaneous

Free Float
N/A
Market Cap
$52.06 billion
Optionable
Optionable
Beta
0.88
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

This page (NASDAQ:ESRX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners